The Versatility of Fragment Screening Approaches and the Application of Fragment Binding Information in Durg DiscoveryStefan Geschwindner, AstraZeneca, speaking at Discovery Chemistry Congress 2012.
Improving Organic Synthesis by Exploiting Flow ReactorProfessor Paul Watts, The University of Hull, speaking at Flow Chemistry Congress.
US Patent Law of 2011 the Good the Bad and the ExpensiveThomas Saunders, Rissman Hendricks & Oliverio, speaking at Drug Chemistry Congress 2012.
Strategic Applications of Flow Chemistry within Drug DiscoveryPaul Richardson, Synthesis Group Leader, Pfizer, speaking at Flow Chemistry Congress.
Protecting IP in Chemistry OutsourcingHiroshi Sheraton, McDermott Will & Emery, speaking at Discovery Chemistry Congress 2012.
Outsourcing in Discovery Chemistry Strategy Selection SuccessHansjoerg Lehmann, Novartis Pharma AG, speaking at Discovery Chemistry Congress 2012.
Outsourcing Chemical Synthesis in the Drug Discovery ProcessGunter Festel, Autodisplay Biotech, speaking at Discovery Chemistry Congress 2012
The Potassium Channels Kv1.3 and KCa3.1 as Targets for Inflammatory Brain PathologiesProfessor Heike Wulff, University of California, speaking at Ion Channel Targets 2011.
Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory EnhancementDr Katumi Sumikawa, University of California, speaking at Ion Channel Targets 2011.
About Us | Advertise On This Site | Cookies | Contact Us | Home | Support | Terms & Conditions